Prevalence and determinants of pharmacy shopping behaviour

Authors

  • H. Buurma PharmD PhD,

    1. SIR Institute for Pharmacy Practice and Policy, Leiden
    2. Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht
    Search for more papers by this author
  • M. L. Bouvy PharmD PhD,

    1. SIR Institute for Pharmacy Practice and Policy, Leiden
    2. Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht
    Search for more papers by this author
  • P. A. G. M. De Smet PharmD PhD,

    1. Scientific Institute of Dutch Pharmacists (WINAp), The Hague
    2. Department of Clinical Pharmacy, University Medical Centre St Radboud, Nijmegen
    Search for more papers by this author
  • A. Floor-Schreudering PharmD,

    1. SIR Institute for Pharmacy Practice and Policy, Leiden
    Search for more papers by this author
  • H. G. M. Leufkens PharmD PhD,

    1. Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht
    Search for more papers by this author
  • A. C. G. Egberts PharmD PhD

    1. Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht
    2. Hospital Pharmacy of University Medical Centre, Utrecht, The Netherlands
    Search for more papers by this author

H. Buurma, Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, PO BOX 80.082, 3508 TB Utrecht, The Netherlands. Tel.: +31 30 2537324; fax: +31 30 2539166; e-mail: h.buurma@stevenshof.nl

Summary

Background and objective:  Discontinuity of care bears the risk of medication errors and poor clinical outcomes. Little is known about the continuity of care related to pharmacies. Therefore, we studied the prevalence and determinants of pharmacy shopping behaviour in the Netherlands.

Methods:  Beneficiaries from a Dutch pharmacy claims database who had visited two or more pharmacies in 2001 were indicated as ‘shoppers’ (n = 45 805). A random sample was taken from all the other beneficiaries who had received at least one prescription: ‘non-shoppers’ (n = 45 805). Shoppers were classified as light (all patients who visited more than one pharmacy at least once in 2001, except for patients defined as heavy or moderate shoppers), moderate (visited 3 or 4 pharmacies and had proportion of prescriptions elsewhere >10% and number of prescriptions elsewhere >10) or heavy (visited 5 or more pharmacies and had proportion of prescriptions elsewhere >10% and number of prescriptions elsewhere >10). Determinants of shopping behaviour were investigated as well as the association between any dispensing of Anatomical Therapeutic Chemical (ATC) classes of drugs and this behaviour.

Results:  10·8% beneficiaries were identified as shoppers: 98·8%‘light shoppers’, 1·0%‘moderate shoppers’ and 0·2%‘heavy shoppers’. Female gender [odds ratio (OR)adj 1·2; 95% confidence interval (CI) 1·1–1·2], younger age (ORadj 1·7; 95%CI 1·7–1·8), the use of ≥3 drugs (ORadj 2·9; 95%CI 2·8–3·0) and visiting different kind of prescribers (ORadj 2·4; 95%CI 2·4–2·5) were associated with shopping behaviour. Shoppers more frequently received at least one prescription for systemic anti-infectives (51·7% vs. 30·8%; OR 2·4; 95%Cl 2·3–2·5) and for nervous system drugs (46·2% vs. 29·3%; OR 2.1; 95%Cl 2·0–2·1).

Conclusions:  Pharmacy shopping behaviour is limited in the Netherlands. However, it may put the patient at risk for unintentional problems, such as drug–drug interactions with anti-infectives. A small proportion of patients exhibit possibly intentional shopping behaviour with psychotropic drugs.

Ancillary